Accellta Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $4M
Latest Deal Amount
  • Investors
  • 4

Accellta General Information

Description

Developer of stem cell culture technologies intended to offer quality human embryonic and induced pluripotent stem cells, progenitors and differentiated cells for drug discovery, regenerative medicine and research. The company's technologies offer uniform cell growth that assists in the mass production of stem cells for therapeutic purposes, research and development applications, enabling clinicians to provide a cost-effective genetic manipulation of the cells with enhanced uniformity and purity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Malat Building
  • Technion City
  • Haifa 3200004
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Accellta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 26-Oct-2014 $4M 000 00.000 Completed Generating Revenue
1. Grant 08-Jan-2014 000.00 Completed Generating Revenue
To view Accellta’s complete valuation and funding history, request access »

Accellta Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Accellta’s complete cap table history, request access »

Accellta Executive Team (6)

Name Title Board Seat Contact Info
Michal Amit Ph.D Co-Founder, Chief Executive Officer & Chief Technology Officer
Yael Garfinkel Chief Financial Officer
Gadi Lipiner Ph.D Manager, Business Development
You’re viewing 3 of 6 executive team members. Get the full list »

Accellta Board Members (7)

Name Representing Role Since
Michael Schickler Ph.D Self Board Member 000 0000
Patrick Zhang Horizons Ventures Board Member 000 0000
Peretz Lavie Accellta Board Member 000 0000
Rona Samler Accellta Board Member 000 0000
Yigal Koltin Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Accellta Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accellta Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alfred Mann Institute at the Technion Accelerator/Incubator Minority 000 0000 000000 0
Horizons Ventures Venture Capital Minority 000 0000 000000 0
Rambam Health Care Campus Corporation Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
To view Accellta’s complete investors history, request access »